Evidence map›Paper›PMID 39187665›Full record

Observational studyAnnals of surgical oncology2024

Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy: Results of Phase I of the PRECINCT Study in 707 Patients.

Aditi Bhatt, Laurent Villeneuve, Armando Sardi, Amine Souadka, Alison Buseck, Brendan J Moran, Basma El Khannousi, Carlos Gonzalez de Pedro, Dario Baratti, Danielle Biacchi and 30 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Aditi BhattDepartment of Surgical Oncology, Zydus Hospital, Ahmedabad, India.
Laurent VilleneuveDepartment of Clinical Research, Centre-Hospitalier Lyon-sud, Lyon, France.
Armando SardiDepartment of Surgical Oncology, Mercy Medical Centre, Baltimore, MD, USA.
Amine SouadkaDepartment of Surgical Oncology, National Cancer Institute, Rabat, Morocco.
Alison BuseckDepartment of Surgical Oncology, Mercy Medical Centre, Baltimore, MD, USA.
Brendan J MoranDepartment of Surgical Oncology, Peritoneal Malignancy Institute, Basingstoke, UK.
Basma El KhannousiDepartment of Pathology, National Cancer Institute, Rabat, Morocco.
Carlos Gonzalez de PedroDepartment of Surgical Oncology, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
Dario BarattiDepartment of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Danielle BiacchiDepartment of Surgical Oncology, Sapienza University of Rome, Rome, Italy.
David MorrisDepartment of Surgical Oncology, St. George Hospital, Sydney, NSW, Australia.
Daniel LabowDepartment of Surgical Oncology, Mount Sinai Hospital, New York, NY, USA.
Edward A LevineSection of Surgical Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Faheez MohamedDepartment of Surgical Oncology, Peritoneal Malignancy Institute, Basingstoke, UK.
Gbadebo AdelekeDepartment of Pathology, Peritoneal Malignancy Institute, Basingstoke, UK.
Gaurav GoswamiDepartment of Radiology, Zydus Hospital, Ahmedabad, India.
Isabelle BonnefoyDepartment of Clinical Research, Centre-Hospitalier Lyon-sud, Lyon, France.
Katherine Cummins PerrySection of Surgical Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Konstantinos I VotanopoulosSection of Surgical Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Loma ParikhDepartment of Pathology, Zydus Hospital, Ahmedabad, India.
Marcello DeracoDepartment of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Mohammad AlyamiDepartment of Surgical Oncology, King Khaled Hospital, Najran, Saudi Arabia.
Noah CohenDepartment of Surgical Oncology, Mount Sinai Hospital, New York, NY, USA.
Nazim BenzerdjebDepartment of Pathology, Centre Hospitalier Lyon-sud, Lyon, France.
Nehal ShahDepartment of Pathology, National Cancer Institute, Rabat, Morocco.
Nezha El BahaouiDepartment of Surgical Oncology, National Cancer Institute, Rabat, Morocco.
Nazanin KhajoueinejadDepartment of Surgical Oncology, Mount Sinai Hospital, New York, NY, USA.
Pascal RoussetDepartment of Radiology, Centre Hospitalier Lyon-sud, Lyon, France.
Perry ShenSection of Surgical Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Shoma BaratDepartment of Surgical Oncology, St. George Hospital, Sydney, NSW, Australia.
Sophia StanfordDepartment of Clinical Research, Peritoneal Malignancy Institute, Basingstoke, UK.
Selma KhouchouaDepartment of Radiology, National Cancer Institute, Rabat, Morocco.
Samantha TroobDepartment of Surgical Oncology, Mount Sinai Hospital, New York, NY, USA.
Sakina ShaikhDepartment of Surgical Oncology, Zydus Hospital, Ahmedabad, India.
Umut SarpelDepartment of Surgical Oncology, Mount Sinai Hospital, New York, NY, USA.
Vadim GushchinDepartment of Surgical Oncology, Mercy Medical Centre, Baltimore, MD, USA.
Vasanth Mark SamuelDepartment of Surgical Oncology, Peritoneal Malignancy Institute, Basingstoke, UK.
Vahan KepenekianDepartment of Surgical Oncology, Centre Hospitalier Lyon-sud, Lyon, Pierre Bénite, France.
Paolo SammartinoDepartment of Surgical Oncology, Sapienza University of Rome, Rome, Italy.
Olivier GlehenDepartment of Surgical Oncology, Centre Hospitalier Lyon-sud, Lyon, Pierre Bénite, France. olivier.glehen@chu-lyon.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe PRECINCT (Pattern of peritoneal dissemination and REsponse to systemic Chemotherapy IN Common and uncommon peritoneal Tumors) is a prospective, multicenter, observational study. This report from phase I of PRECINCT outlines variations in recording the surgical peritoneal cancer index (sPCI) at experienced peritoneal malignancy centers and the incidence of pathologically confirmed disease in morphologically different peritoneal lesions (PL).

methodsThe sPCI was recorded in a prespecified format that included the morphological appearance of PL. Six prespecified morphological terms were provided. The surgical and pathological findings were compared.

resultsFrom September 2020 to December 2021, 707 patients were enrolled at 10 centers. The morphological details are routinely recorded at two centers, structure bearing the largest nodule, and exact size of the largest tumor deposit in each region at four centers each. The most common morphological terms used were normal peritoneum in 3091 (45.3%), tumor nodules in 2607 (38.2%) and confluent disease in 786 (11.5%) regions. The incidence of pathologically confirmed disease was significantly higher in 'tumor nodules' with a lesion score of 2/3 compared with a lesion score of 1 (63.1% vs. 31.5%; p < 0.001). In patients receiving neoadjuvant chemotherapy, the incidence of pathologically confirmed disease did not differ significantly from those undergoing upfront surgery [751 (47.7%) and 532 (51.4%) respectively; p = 0.069].

conclusionsThe sPCI was recorded with heterogeneity at different centers. The incidence of pathologically confirmed disease was 49.2% in 'tumor nodules'. Frozen section could be used more liberally for these lesions to aid clinical decisions. A large-scale study involving pictorial depiction of different morphological appearances and correlation with pathological findings is indicated.

Indexed as

Cytoreduction Surgical ProceduresLaparotomyPeritoneal NeoplasmsAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisProspective StudiesCytoreductive surgeryMorphology of peritoneal lesionsPeritoneal cancer indexPeritoneal metastasesPeritoneal surface malignancySurgical PCI

Identifiers

PMID39187665
PMCPMC11549162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.